 Catherine A Phillips MD
| Title | Associate Professor |
|---|
| Institution | University of Massachusetts Medical School |
|---|
| Department | Neurology |
|---|
| Address | University of Massachusetts Medical School
55 Lake Avenue North
Worcester MA 01655
|
|---|
| Phone | 508-856-4147 |
|---|
| vCard | Download vCard |
|---|
|
|
|
|
| Institution | UMMS - School of Medicine |
|---|
| Department | Neurology |
|---|
|
|
|---|
|
 Biography | Oberlin College, Oberlin, OH, United States | BA | | Arts | | University of California, San Francisco, San Francisco, CA, United States | MD | | |
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
-
Mah L, Swearer J, Phillips CA, Benjamin S. Reduction in apathy following epilepsy surgery. Neuropsychiatr Dis Treat. 2019; 15:1679-1684. PMID: 31388300.
-
Wright SE, Rewers-Felkins KA, Quinlin IS, Phillips CA, Townsend M, Philip R, Dobrzanski MJ, Lockwood-Cooke PR, Robinson W. Cytotoxic T-lymphocyte immunotherapy for ovarian cancer: a pilot study. J Immunother. 2012 Feb-Mar; 35(2):196-204. PMID: 22306908.
-
Dobrzanski MJ, Rewers-Felkins KA, Samad KA, Quinlin IS, Phillips CA, Robinson W, Dobrzanski DJ, Wright SE. Immunotherapy with IL-10- and IFN-?-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer. Cancer Immunol Immunother. 2012 Jun; 61(6):839-54. PMID: 22083345.
-
Wright SE, Quinlin IS, Rewers-Felkins KA, Dombrowski KE, Phillips CA. Retention of immunogenicity produced by mucin 1 peptides with glycosylation site substitutions. Immunopharmacol Immunotoxicol. 2010 Dec; 32(4):647-55. PMID: 20470225.
-
Wright SE, Rewers-Felkins KA, Quinlin IS, Phillips CA, Townsend M, Philip R, Zorsky P, Klug P, Dai L, Hussain M, Thomas AA, Sundaramurthy C. Number of treatment cycles influences development of cytotoxic T cells in metastatic breast cancer patients - a phase I/II study. Immunol Invest. 2010; 39(6):570-86. PMID: 20653425.
-
Dobrzanski MJ, Rewers-Felkins KA, Quinlin IS, Samad KA, Phillips CA, Robinson W, Dobrzanski DJ, Wright SE. Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival. Clin Immunol. 2009 Dec; 133(3):333-52. PMID: 19762283.
-
Wright SE, Rewers-Felkins KA, Quinlin IS, Phillips CA, Townsend M, Philip R, Zorsky P, Klug P, Dai L, Hussain M, Thomas AA, Sundaramurthy C. Tumor burden influences cytotoxic T cell development in metastatic breast cancer patients--a phase I/II study. Immunol Invest. 2009; 38(8):820-38. PMID: 19860591.
-
Wright SE, Rewers-Felkins KA, Quinlin IS, Fogler WE, Phillips CA, Townsend M, Robinson W, Philip R. MHC-unrestricted lysis of MUC1-expressing cells by human peripheral blood mononuclear cells. Immunol Invest. 2008; 37(3):215-25. PMID: 18389441.
-
Orr MK, Burnside JS, Phillips CA, Philip R, Dombrowski KE, Wright SE. MHC-restricted presentation of a single repeat of MUC1 mucin. Immunol Invest. 2007; 36(3):271-83. PMID: 17558710.
-
Wright SE, Rewers-Felkins KA, Quinlin IS, Eldridge PW, Zorsky PE, Klug PP, Phillips CA, Philip R. Adoptive immunotherapy of mucin1 expressing adenocarcinomas with mucin1 stimulated human peripheral blood mononuclear cells. Int J Mol Med. 2002 Apr; 9(4):401-4. PMID: 11891536.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2002 | 1 | | 2007 | 1 | | 2008 | 1 | | 2009 | 2 | | 2010 | 2 | | 2011 | 1 | | 2012 | 1 | | 2019 | 1 |
To return to the timeline, click here.
For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
|
Phillips's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|